文献速递心脑血管急症

重楼皂苷I通过核因子-κB信号通路减轻大鼠心肌缺血/再灌注损伤

[Polyphyllin I alleviates myocardial ischemia/reperfusion injury via nuclear factor-ΚB signal pathway].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2019-01-01
一句话结论大鼠心肌缺血/再灌注模型中,重楼皂苷I预处理可减小梗死面积、减少心肌细胞凋亡并抑制NF-κB P65核转位,150 mg×kg-1×d-1效果最明显。

该研究将6月龄SD大鼠随机分为假手术组、缺血/再灌注模型组及重楼皂苷I低、中、高剂量组,每组10只;模型组和给药组通过结扎左冠状动脉前降支30分钟、再灌注120分钟制备心肌缺血/再灌注模型,假手术组仅开胸不结扎。低、中、高剂量组分别经灌胃给予重楼皂苷I 75、150、300 mg×kg-1×d-1预处理4周,模型组灌胃二甲基亚砜。结果显示,与模型组相比,各剂量重楼皂苷I预处理均显著减小心肌梗死面积、降低心肌细胞凋亡率、上调Bcl-2并下调Bax表达;中、高剂量组还显著减少P65核转位。中、高剂量组之间各指标无显著差异。作者认为重楼皂苷I通过NF-κB信号通路减轻大鼠心肌缺血/再灌注损伤,其中150 mg×kg-1×d-1的效果最明显。

要点

  • 在大鼠心肌缺血/再灌注模型中,重楼皂苷I低、中、高剂量预处理均使心肌梗死面积显著小于模型组:分别为(21.6±0.9)%、(14.3±1.6)%、(15.0±0.8)% vs. (29.6±1.4)%。
  • 重楼皂苷I预处理使心肌细胞凋亡率显著低于模型组:低、中、高剂量分别为(38.6±1.9)%、(24.3±2.6)%、(26.3±2.8)% vs. (56.8±2.4)%。
  • 重楼皂苷I预处理使Bcl-2蛋白表达显著高于模型组、Bax显著低于模型组:Bcl-2/GAPDH分别为0.24±0.07、0.36±0.02、0.34±0.09 vs. 0.13±0.04;Bax/GAPDH分别为0.39±0.10、0.21±0.08、0.23±0.06 vs. 0.53±0.12。
  • 中、高剂量重楼皂苷I预处理使P65核转位显著低于模型组:核内P65/Histone 3分别为0.49±0.09、0.51±0.06 vs. 0.83±0.11;胞质P65/GAPDH分别为0.31±0.03、0.30±0.05 vs. 0.22±0.07。
  • 中剂量与高剂量重楼皂苷I组之间各指标差异均无统计学意义(均P > 0.05),作者认为150 mg×kg-1×d-1的效果最明显。

适用人群与场景

  • 6月龄Sprague-Dawley(SD)大鼠,采用随机数字表法分为假手术组、缺血/再灌注模型组及重楼皂苷I低、中、高剂量组,每组10只。
  • 缺血/再灌注模型组及重楼皂苷I各剂量组通过结扎左冠状动脉前降支30分钟、再灌注120分钟制备心肌缺血/再灌注模型;假手术组仅开胸不结扎。
  • 低、中、高剂量重楼皂苷I组分别在造模前灌胃给予重楼皂苷I 75、150、300 mg×kg-1×d-1预处理4周;缺血/再灌注模型组灌胃二甲基亚砜(DMSO)。

处置流程与药物剂量

  • 重楼皂苷I低、中、高剂量组分别以75、150、300 mg×kg-1×d-1灌胃预处理4周,每日一次(按mg×kg-1×d-1表述),用于大鼠心肌缺血/再灌注模型建立前。
  • 缺血/再灌注模型组以二甲基亚砜(DMSO)灌胃。
  • 再灌注结束后采用三苯基四氮唑(TTC)与伊文思蓝(EB)染色测定心肌梗死面积,采用TdT介导dUTP缺口末端标记(TUNEL)染色检测心肌细胞凋亡,采用Western Blot检测Bax、Bcl-2及NF-κB信号通路P65的胞质与核内表达。

研究设计与关键结果

  • 研究类型:动物实验;样本量:每组10只,共5组(假手术组、缺血/再灌注模型组、重楼皂苷I低、中、高剂量组);人群:6月龄SD大鼠;干预:重楼皂苷I 75、150、300 mg×kg-1×d-1灌胃预处理4周;对照:缺血/再灌注模型组灌胃DMSO,假手术组仅开胸不结扎。
  • 与假手术组比较,缺血/再灌注模型组心肌梗死面积显著增大、心肌细胞凋亡率显著升高、Bcl-2表达显著降低、Bax表达显著升高、P65核转位显著增加。
  • 与缺血/再灌注模型组比较,重楼皂苷I低、中、高剂量预处理均显著减小心肌梗死面积:分别为(21.6±0.9)%、(14.3±1.6)%、(15.0±0.8)% vs. (29.6±1.4)%,差异均有统计学意义(均P < 0.05)。
  • 与缺血/再灌注模型组比较,重楼皂苷I低、中、高剂量预处理均显著降低心肌细胞凋亡率:分别为(38.6±1.9)%、(24.3±2.6)%、(26.3±2.8)% vs. (56.8±2.4)%,差异均有统计学意义(均P < 0.05)。
  • 与缺血/再灌注模型组比较,重楼皂苷I低、中、高剂量预处理均显著升高Bcl-2蛋白表达、降低Bax蛋白表达:Bcl-2/GAPDH分别为0.24±0.07、0.36±0.02、0.34±0.09 vs. 0.13±0.04;Bax/GAPDH分别为0.39±0.10、0.21±0.08、0.23±0.06 vs. 0.53±0.12,差异均有统计学意义(均P < 0.05)。
  • 与缺血/再灌注模型组比较,中、高剂量重楼皂苷I预处理后P65核转位显著减少:核内P65/Histone 3分别为0.49±0.09、0.51±0.06 vs. 0.83±0.11;胞质P65/GAPDH分别为0.31±0.03、0.30±0.05 vs. 0.22±0.07,差异均有统计学意义(均P < 0.05)。
  • 中剂量与高剂量重楼皂苷I组之间各指标差异均无统计学意义(均P > 0.05)。

证据类型、等级与局限

  • 证据类型:动物实验(大鼠心肌缺血/再灌注模型)。
  • 作者结论:重楼皂苷I通过NF-κB信号通路减轻大鼠心肌缺血/再灌注损伤,其中150 mg×kg-1×d-1的效果最明显。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 该研究为大鼠实验,作者认为重楼皂苷I通过NF-κB信号通路减轻心肌缺血/再灌注损伤,150 mg×kg-1×d-1效果最明显;原文未据此给出临床推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To investigate the protective effect of Polyphyllin I (PPI) on myocardial ischemia/reperfusion (I/R) injury in rats and its mechanism.

METHODS: The 6-month-old Sprague-Dawley (SD) rats were divided into sham operation group (Sham group), I/R model group, and low, medium, high dose PPI groups according to the random number table method, with 10 in each group. The rat myocardial I/R model was prepared by ligating the left anterior descending branch of the coronary artery by 30 minutes and reperfusion by 120 minutes. Sham group was exposure to open chest without ligation. Low, medium, high dose PPI groups were injected with PPI 75, 150, 300 mg×kg-1×d-1 in front of the film for 4 weeks; dimethyl sulfoxide (DMSO) was gastric infused in the I/R model group. After the end of reperfusion, the myocardial infarction area (IA) was determined by triphenyltetrazole (TTC) and Evans blue (EB) staining; the apoptosis of myocardial cells was detected by TdT-mediated dUTP nick end labeling stain (TUNEL); the expressions of apoptosis related protein (Bax, Bcl-2), and cytoplasmic and nucleus expressions of P65 in nuclear factor-ΚB (NF-ΚB) signal pathway were detected by Western Blot.

RESULTS: Compared with the Sham group, the myocardial IA was significantly increased in the I/R model group, the apoptosis rate of myocardial cells was significantly increased, the expression of Bcl-2 was significantly decreased, and the expression of Bax was significantly increased, and the intranuclear transfer of P65 was significantly increased. Compared with the I/R model group, low, medium and high dose PPI pretreatment could significantly reduce the myocardial IA [(21.6±0.9)%, (14.3±1.6)%, (15.0±0.8)% vs. (29.6±1.4)%], the apoptosis rate of myocardial cells was significantly decreased [(38.6±1.9)%, (24.3±2.6)%, (26.3±2.8)% vs. (56.8±2.4)%], the protein expression of Bcl-2 was significantly increased, while the protein expression of Bax was significantly decreased (Bcl-2/GAPDH: 0.24±0.07, 0.36±0.02, 0.34±0.09 vs. 0.13±0.04; Bax/GAPDH: 0.39±0.10, 0.21±0.08, 0.23±0.06 vs. 0.53±0.12); and P65 nuclear transfer was significantly decreased after middle and high dose PPI pretreatment [nuclear P65/Histone 3: 0.49±0.09, 0.51±0.06 vs. 0.83±0.11; cytoplasmic P65/GAPDH: 0.31±0.03, 0.30±0.05 vs. 0.22±0.07], with statistically significant differences (all P < 0.05). However, there was no significant difference in each index between the medium and high dose PPI groups (all P > 0.05).

CONCLUSIONS: PPI alleviates myocardial I/R injury in rats via NF-ΚB signal pathway, and the PPI effect of 150 mg×kg-1×d-1 is most especially significant.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Yang L, Yuan Y, Wu Y, et al. [Polyphyllin I alleviates myocardial ischemia/reperfusion injury via nuclear factor-ΚB signal pathway]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019. PMID: 31315735. doi:10.3760/cma.j.issn.2095-4352.2019.06.017

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。